Brain Cannabinoid CB2 Receptor in Schizophrenia
Hiroki Ishiguro(University of Tsukuba), Tadao Arinami(Japan Science and Technology Agency), Akiyoshi Kakita(Niigata University), Hiroshi Ujike(Okayama University), Masanari Itokawa(Fujita Health University), Nakao Iwata(Fujita Health University), Hiroshi Kunugi(National Center of Neurology and Psychiatry), Miyuki Morikawa(University of Tsukuba), Norio Ozaki(Nagoya University), Yoshimi Suzuki(University of Tsukuba), Izumi Naka(The University of Tokyo), Kazuhiro Niizato(Tokyo Metropolitan Matsuzawa Hospital), Toshiyuki Someya(Niigata University), Emmanuel S. Onaivi(William Paterson University), Hiroyuki Nawa(Wakayama Medical University), Hitoshi Takahashi(Niigata University), Yuichiro Watanabe(Niigata University), Tsukasa Sasaki(Bunkyo University), Jun Ohashi(The University of Tokyo), Yasue Horiuchi(National Taiwan University), Toshiya Inada(Nagoya University), Keiko Imai(University of Tsukuba), Minori Koga(Japan Science and Technology Agency), Makoto Takahashi(Iwate Medical University), Shyuji Iritani(Tokyo Metropolitan Matsuzawa Hospital), Makoto Arai(Tokyo Metropolitan Institute of Medical Science)
Cited by 184
Related Papers
Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA)
|Nature Genetics|1994|1.1k
Structure-based classification of tauopathies
|Nature|2021|916
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Comparative genetic architectures of schizophrenia in East Asian and European populations
|Nature Genetics|2019|709